What blood work should I get before and during peptide therapy?

Before starting peptide therapy, baseline testing typically includes a complete blood count (CBC), comprehensive metabolic panel for liver and kidney function, hormone levels, and lipid panel. Ongoing monitoring is recommended at 4 weeks after starting, then every 3-6 months, checking hematocrit levels (therapy should pause if above 54% due to blood clot risk), liver enzymes, hormone panels, and inflammatory markers. Long-term maintenance usually requires bloodwork yearly or twice yearly once levels stabilize.